Cart 0 items

Comparison

Tirzepatide vs Retatrutide

The current frontier of incretin research: a dual agonist against a triple agonist. The added receptor is glucagon, and it changes what the compound is studied for rather than simply how much it does.

What is the difference between tirzepatide and retatrutide?

Tirzepatide is the established dual-agonist comparator with the larger body of published work behind it. Retatrutide is where the glucagon arm enters, which is a genuinely different mechanism rather than more of the same: appetite and glucose signalling are joined by energy expenditure. Because it is not approved anywhere, research supply is the only route to it, which is why demand is concentrated there right now.

Side by side

Property Tirzepatide Retatrutide
Receptor targets GIP and GLP-1 GIP, GLP-1 and glucagon
Class Dual agonist Triple agonist
Added pathway None beyond the two incretins Glucagon receptor, recruiting energy expenditure
Molar mass 4813.45 g/mol 4731.35 g/mol
Regulatory status Approved in major markets Not approved in any market
Availability Widely available Research supply only
Price $85.00 · 10 mg $89.00 · 10 mg

Both compounds

Tirzepatide

Tirzepatide

10 mg

Dual GIP and GLP-1 receptor agonist, 10 mg per vial.

CAS
2023788-19-2
Storage
Refrigerated

$85.00

In stock

Retatrutide

Retatrutide

10 mg

Triple GIP, GLP-1 and glucagon receptor agonist, 10 mg per vial.

CAS
2381089-83-2
Storage
Refrigerated

$89.00

Low stock

Questions

What does the glucagon receptor add to a triple agonist?

Glucagon receptor activity recruits energy expenditure, a mechanism the two incretin receptors do not cover. That is what separates a triple agonist from a dual agonist rather than any difference in incretin potency.

Is retatrutide approved?

No. It is not approved in any market, and approval is not expected before 2027 at the earliest. Research supply is therefore the only route to the compound.

Why is retatrutide so heavily requested?

It is the newest molecule in the class, it adds a mechanism the others do not have, and it is unavailable through any approved channel. Those three together concentrate research demand on it.

Other comparisons

All products listed are sold strictly for in-vitro laboratory research and analytical use. They are not drugs, foods, cosmetics or medical devices, and are not intended to diagnose, treat, cure or prevent any disease.